Stockbabie NewsFatherMarketNewsMarket Intelligence
MARKETS
Wire · Technology
Technology

Ruanyun Edai Technology Inks Agreement To Grant License To BioNexus Gene Lab For Its Cogni AI Document-Intelligence Platform For Healthcare In Malaysia

Oct 5, 2026 · 09:02 AM ET· updated 1h ago

Ruanyun Edai Technology Inc. (NASDAQ: RYET) ("RYET" or the "Company") today announced that it has signed a definitive agreement under which, on closing, RYET would grant BioNexus Gene Lab Corp.

Share
Why It Matters

Ruanyun Edai is letting another company use its AI document software in Malaysia. This shows the company found a customer for its technology in healthcare.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
RYET0.83
-0.03 (-3.48%)
BGLC1.30
+0.03 (+2.05%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.